California's New Task: A $155 Million Drive to Make Stem Cell Therapies Affordable and Accessible

Dec 17, 2020

∙ Paid

The enormous cost of stem cell therapies is
a fresh target for CIRM.

Proposition 14, California's $5.5 billion stem cell ballot initiative, is coming home to roost, so to speak.

Next Monday, the governing board of the state stem cell agency is scheduled to begin to settle in under the new measure, which does much more than save the agency's financial li…

Keep reading with a 7-day free trial

Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.